Matching-Adjusted Indirect Comparison of Tarlatamab for Patients with Platinum-Refractory or Platinum-Resistant Extensive-Stage Small-Cell Lung Cancer

Lung, Respiratory and Thoracic Cancer
Do you want to read an article? Please log in or register.